BCPC - Balchem Corp Stock Price, Fair Value and News

154.61USD-1.82 (-1.16%)Market Closed

Market Summary

USD154.61-1.82

Market Closed

-1.16%

BCPC Alerts

1 major insider sales recently.

BCPC Stock Price

View Fullscreen

BCPC RSI Chart

BCPC Valuation

Market Cap

5.0B

Price/Earnings (Trailing)

43.66

Price/Sales (Trailing)

5.39

EV/EBITDA

27.9

Price/Free Cashflow

27.5

BCPC Price/Sales (Trailing)

BCPC Profitability

Operating Margin

33.39%

EBT Margin

15.60%

Return on Equity

10.64%

Return on Assets

7.23%

Free Cashflow Yield

3.64%

BCPC Fundamentals

BCPC Revenue

Revenue (TTM)

929.6M

Rev. Growth (Yr)

3.06%

Rev. Growth (Qtr)

4.79%

BCPC Earnings

Earnings (TTM)

114.8M

Earnings Growth (Yr)

27.64%

Earnings Growth (Qtr)

8.77%

Breaking Down BCPC Revenue

Last 7 days

0.8%

Last 30 days

4.5%

Last 90 days

10.0%

Trailing 12 Months

23.2%

How does BCPC drawdown profile look like?

BCPC Financial Health

Current Ratio

2.61

Debt/Equity

0.14

Debt/Cashflow

1.17

BCPC Investor Care

Shares Dilution (1Y)

0.61%

Diluted EPS (TTM)

3.54

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	929.6M	0	0	0
2023	946.0M	940.6M	926.3M	922.4M
2022	842.2M	876.6M	923.0M	942.4M
2021	714.9M	743.9M	766.6M	799.0M
2020	661.1M	672.9M	689.5M	703.6M
2019	639.3M	637.2M	640.7M	643.7M
2018	618.5M	635.1M	639.4M	643.7M
2017	555.8M	564.1M	576.3M	594.8M
2016	542.8M	546.8M	545.2M	553.2M
2015	600.3M	602.8M	582.4M	552.5M
2014	338.5M	387.5M	460.3M	541.4M
2013	318.8M	323.1M	335.6M	337.2M
2012	295.1M	299.4M	300.1M	310.4M
2011	268.2M	281.4M	291.9M	291.9M
2010	228.3M	237.3M	246.2M	255.1M
2009	0	0	0	219.4M

Get all data in R, Python etc through our Historical Stock Data APIs

GRUFITY'S FAIR VALUE MODEL

Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed Russell 2000 Index

Small Caps and Mid Caps are mostly overlooked by investors as all the focus goes to Magnificent 7. These stocks that are not part of the beauty contest require a deeper look. However, all large cap stocks were once small caps. Grufity's Fair Value model opens up this unverse as it separates high-performing, rewarding stocks from low-performing risky stocks. <b>Russell 2000 stocks that were marked 'Very Cheap' by the model doubled in three years while the index was flat.</b>

Returns of $10,000 invested in:

Very Cheap Stocks: $21,859
Russell 2000 Index: $10,334
Very Expensive Stocks: $8,224

Russell 2000 stocks considered 'Very Cheap' by the model greatly outperformed Russell 2000 index and the 'Very Expensive' bucket over past three years.

Russell 2000 Index

Very Expensive Stocks

Very Cheap Stocks

Try For Just $1.99

Tracking the Latest Insider Buys and Sells of Balchem Corp

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
May 08, 2024	fischer david b	sold	-764,902	152	-5,000	-
Mar 08, 2024	tignor michael brent	acquired	358,680	85.4	4,200	svp & chief hr officer
Mar 08, 2024	tignor michael brent	sold	-840,985	157	-5,339	svp & chief hr officer
Mar 04, 2024	wineinger matthew david	sold	-209,128	156	-1,333	-
Feb 26, 2024	backus william a.	sold	-1,086,300	155	-7,000	vp & chief accounting officer
Feb 23, 2024	backus william a.	acquired	738,421	80.438	9,180	vp & chief accounting officer
Feb 23, 2024	backus william a.	sold	-1,435,470	156	-9,180	vp & chief accounting officer
Feb 22, 2024	harris theodore l	sold	-5,300,030	154	-34,350	chairman, president & ceo
Feb 22, 2024	harris theodore l	acquired	2,030,400	59.1091	34,350	chairman, president & ceo
Feb 21, 2024	sestrick michael robert	acquired	871,999	78.5585	11,100	svp & chief technology officer

Which funds bought or sold BCPC recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
May 10, 2024	PNC Financial Services Group, Inc.	reduced	-12.99	-119,290	1,154,910	-%
May 10, 2024	FIRST NATIONAL BANK OF OMAHA	reduced	-5.05	-25,047	2,270,020	0.14%
May 10, 2024	McIlrath & Eck, LLC	unchanged	-	322	8,057	-%
May 10, 2024	CHESAPEAKE CAPITAL CORP /IL/	new	-	824,644	824,644	0.61%
May 10, 2024	Covestor Ltd	added	1.25	1,000	13,000	0.01%
May 10, 2024	BlackRock Inc.	reduced	-0.86	24,278,300	766,444,000	0.02%
May 10, 2024	OSAIC HOLDINGS, INC.	reduced	-72.05	-728,723	299,254	-%
May 10, 2024	Y-Intercept (Hong Kong) Ltd	new	-	355,610	355,610	0.03%
May 10, 2024	CIBC Private Wealth Group, LLC	new	-	40,160	40,160	-%
May 10, 2024	JPMORGAN CHASE & CO	added	18.69	14,228,500	74,431,100	0.01%

Are Funds Buying or Selling BCPC?

Are funds buying BCPC calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own BCPC

No. of Funds

BCPC Alerts

1 major insider sales recently.

Unveiling Balchem Corp's Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Feb 13, 2024	vanguard group inc	11.76%	3,791,512	SC 13G/A
Feb 09, 2024	wasatch advisors lp	-	0	SC 13G/A
Feb 07, 2024	apg asset management us inc.	9.0%	2,917,112	SC 13G/A
Jan 22, 2024	blackrock inc.	15.5%	4,989,247	SC 13G/A
Feb 09, 2023	wasatch advisors inc	-	0	SC 13G/A
Feb 09, 2023	vanguard group inc	11.95%	3,841,468	SC 13G/A
Jan 26, 2023	blackrock inc.	15.5%	4,972,536	SC 13G/A
Jan 20, 2023	blackrock inc.	15.5%	4,972,536	SC 13G/A
Jan 12, 2023	apg asset management us inc.	8.5%	2,719,969	SC 13G/A
Feb 11, 2022	wasatch advisors inc	-	0	SC 13G

Recent SEC filings of Balchem Corp

View All Filings

Date Filed	Form Type	Document
May 13, 2024	4	Insider Trading
May 10, 2024	144	Notice of Insider Sale Intent
May 10, 2024	4	Insider Trading
May 08, 2024	144	Notice of Insider Sale Intent
May 03, 2024	10-Q	Quarterly Report
May 03, 2024	8-K	Current Report
Apr 26, 2024	DEF 14A	DEF 14A
Apr 26, 2024	DEFA14A	DEFA14A
Mar 29, 2024	8-K	Current Report
Mar 12, 2024	4	Insider Trading

Peers (Alternatives to Balchem Corp)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
APD	55.7B	12.2B	8.12%	-9.95%	22.55	4.58	-7.47%	13.44%
DOW	41.8B	43.5B	2.91%	13.50%	32.96	0.96	-18.61%	-57.39%
CE	17.5B	10.7B	2.74%	59.05%	8.8	1.64	7.11%	34.19%
AVTR	16.5B	6.9B	-2.68%	20.01%	63.46	2.4	-6.48%	-57.90%
ALB	15.5B	8.4B	7.29%	-32.83%	45.82	1.84	-4.27%	-90.82%
EMN	11.9B	9.1B	3.11%	28.37%	12.85	1.31	-11.38%	33.67%
MID-CAP
CBT	5.6B	3.9B	9.48%	47.75%	12.64	1.44	-8.19%	39.97%
BCPC	5.0B	929.6M	4.54%	23.17%	43.66	5.39	-1.74%	15.81%
AVNT	4.2B	3.1B	10.25%	17.84%	39.53	1.33	-6.69%	-83.56%
ARCH	2.9B	3.0B	2.14%	29.62%	9.05	0.98	-20.68%	-74.38%
SMALL-CAP
CCF	1.2B	404.0M	0.11%	32.60%	36.59	3	24.06%	-25.72%
ASIX	672.6M	1.5B	-8.67%	-24.85%	295.92	0.46	-21.27%	-97.94%
CMT	179.8M	336.4M	6.91%	-3.82%	9.86	0.53	-12.92%	28.47%
AREC	103.7M	16.7M	-5.76%	-12.08%	-8.76	6.19	-57.58%	-718.66%
AMRS	3.7M	-	-80.00%	-99.58%	-0.01	0.01	-	-

Balchem Corp News

Latest updates

Balchem Corp Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Income Statement (Quarterly)																					(In Millions)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Revenue	4.8%	240	229	230	231	233	233	244	237	229	213	198	202	186	181	175	173	174	167	159	162	157
Cost Of Revenue	2.9%	158	154	153	154	159	164	176	165	157	149	137	143	127	124	119	118	119	112	105	108	108
Gross Profit	8.7%	82.00	75.00	77.00	77.00	73.00	69.00	68.00	72.00	72.00	64.00	61.00	59.00	59.00	57.00	56.00	55.00	55.00	54.00	54.00	54.00	49.00
Operating Expenses	8.7%	40.00	37.00	33.00	35.00	39.00	35.00	35.00	32.00	33.00	30.00	28.00	29.00	28.00	28.00	27.00	28.00	29.00	31.00	28.00	28.00	23.00
S&GA Expenses	-5.4%	18.00	19.00	18.00	19.00	18.00	18.00	17.00	16.00	17.00	15.00	15.00	15.00	15.00	15.00	14.00	14.00	15.00	16.00	15.00	15.00	14.00
R&D Expenses	4.2%	4.00	4.00	4.00	4.00	3.00	3.00	3.00	3.00	3.00	5.00	3.00	3.00	3.00	2.00	3.00	3.00	3.00	3.00	3.00	3.00	3.00
EBITDA Margin	3.9%	0.19*	0.18*	0.17*	0.17*	0.17*	0.19*	0.20*	0.21*	0.21*	0.21*	0.22*	0.22*	-	-	-	-	-	-	-	-	-
Interest Expenses	-2.0%	-5.40	-5.29	-6.59	-5.16	-5.56	-5.12	-3.64	-0.96	-0.55	-0.57	-0.56	-0.61	-0.72	-0.83	-0.95	-0.96	-1.70	-1.21	-1.67	-1.49	-1.59
Income Taxes	18.8%	8.00	7.00	7.00	8.00	6.00	4.00	6.00	9.00	9.00	8.00	7.00	7.00	7.00	6.00	6.00	5.00	5.00	2.00	4.00	5.00	6.00
Earnings Before Taxes	10.8%	37.00	33.00	36.00	38.00	29.00	26.00	31.00	39.00	38.00	33.00	32.00	30.00	30.00	28.00	28.00	26.00	24.00	22.00	24.00	25.00	25.00
EBT Margin	4.8%	0.16*	0.15*	0.14*	0.13*	0.13*	0.14*	0.15*	0.16*	0.16*	0.16*	0.16*	0.16*	-	-	-	-	-	-	-	-	-
Net Income	8.8%	29.00	27.00	29.00	30.00	23.00	21.00	25.00	30.00	29.00	25.00	25.00	23.00	23.00	22.00	22.00	21.00	20.00	20.00	21.00	20.00	19.00
Net Income Margin	5.0%	0.12*	0.12*	0.11*	0.11*	0.10*	0.11*	0.12*	0.12*	0.12*	0.12*	0.12*	0.12*	-	-	-	-	-	-	-	-	-
Free Cashflow	-50.5%	33.00	67.00	40.00	29.00	29.00	35.00	35.00	42.00	1.00	38.00	33.00	30.00	-	-	-	-	-	-	-	-	-

Balance Sheet

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet																					(In Millions)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Assets	-0.5%	1,589	1,597	1,603	1,619	1,629	1,625	1,633	1,607	1,195	1,199	1,179	1,174	1,169	1,166	1,161	1,151	1,162	1,156	1,097	1,098	972
Current Assets	3.4%	325	314	341	337	336	336	368	377	320	322	300	287	281	267	270	264	271	255	240	232	222
Cash Equivalents	-6.4%	60.00	64.00	77.00	67.00	60.00	67.00	56.00	76.00	64.00	103	90.00	80.00	89.00	85.00	79.00	76.00	74.00	66.00	59.00	42.00	39.00
Inventory	0.8%	110	110	116	125	125	120	139	141	108	91.00	82.00	78.00	77.00	71.00	77.00	82.00	83.00	84.00	74.00	68.00	67.00
Net PPE	-0.7%	274	276	269	271	276	271	260	252	240	238	230	228	227	228	220	217	215	217	201	204	188
Goodwill	-0.9%	772	779	767	774	774	770	749	216	523	524	525	527	526	529	526	523	523	524	504	507	446
Liabilities	-6.1%	510	543	578	612	655	686	737	705	321	322	290	304	320	338	342	359	396	412	363	366	261
Current Liabilities	-16.2%	124	148	108	114	117	140	142	144	124	144	105	101	89.00	94.00	68.00	68.00	72.00	92.00	72.00	62.00	64.00
LT Debt, Current	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	2.00	-	-	-
Shareholder's Equity	2.4%	1,079	1,054	1,025	1,007	973	938	896	901	874	877	889	870	849	828	819	793	766	744	734	732	711
Retained Earnings	3.2%	926	897	896	867	837	814	816	791	761	732	728	703	680	657	653	632	611	591	587	567	547
Additional Paid-In Capital	5.7%	154	146	141	137	132	129	125	121	117	148	173	173	171	165	175	174	174	174	174	170	167
Shares Outstanding	0.5%	32.00	32.00	32.00	32.00	32.00	32.00	32.00	32.00	32.00	32.00	32.00	32.00	-	-	-	-	-	-	-	-	-
Float	-	-	-	-	4,321	-	-	-	4,133	-	-	-	4,224	-	-	-	3,046	-	-	-	3,212	-

Cashflow (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Cashflow (Quarterly)																					(In Thousands)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Cashflow From Operations	-50.5%	33,388	67,406	46,526	34,991	34,838	41,655	41,620	48,240	7,021	44,491	39,634	35,782	40,607	47,954	35,360	44,615	22,565	32,967	42,682	26,329	22,483
Share Based Compensation	25.5%	4,750	3,785	3,749	3,748	4,770	3,386	2,949	3,812	3,077	1,993	2,895	3,292	2,622	1,548	2,254	2,320	2,181	1,879	2,095	1,991	1,631
Cashflow From Investing	43.2%	-6,739	-11,865	-9,276	-3,611	-10,061	-14,489	-85,113	-306,340	-10,072	-14,181	-7,599	-7,294	-6,226	-13,211	-7,787	-8,199	-5,394	-53,116	4,566	-101,895	-5,780
Cashflow From Financing	57.2%	-30,023	-70,146	-25,098	-24,759	-33,318	-21,401	28,386	274,539	-34,845	-15,945	-20,506	-37,794	-27,933	-31,545	-26,692	-34,767	-8,160	25,760	-28,669	77,868	-31,574
Dividend Payments	-	25,555	-	3.00	2.00	22,867	5.00	4.00	1.00	20,703	19.00	4.00	-	18,700	1.00	-	-	16,704	-	-	-	15,135
Buy Backs	1071.6%	5,202	444	101	75.00	3,849	178	46.00	600	34,599	16,477	7,927	9,239	1,596	7,481	2,957	2,134	891	-	20,594	-	727

Get Full Access to Grufity – and Unlimited Downloads

Gain full access to fair value, watchlists, stock screener, unlimited page visits, and additional features by joining as a member today for just $1.99.

Try For Just $1.99

BCPC Income Statement

2024-03-31

Condensed Consolidated Statements of Earnings - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Income Statement [Abstract]
Net sales	$ 239,659	$ 232,540
Cost of sales	158,145	159,370
Gross margin	81,514	73,170
Operating expenses:
Selling expenses	18,227	18,183
Research and development expenses	4,100	3,450
General and administrative expenses	17,511	17,129
Total operating expenses	39,838	38,762
Earnings from operations	41,676	34,408
Other expenses, net:
Interest expense, net	5,398	5,565
Other income, net	(572)	(276)
Total other (income) expenses	4,826	5,289
Earnings before income tax expense	36,850	29,119
Income tax expense	7,864	6,409
Net earnings	$ 28,986	$ 22,710
Net earnings per common share - basic (in dollars per share)	$ 0.90	$ 0.71
Net earnings per common share - diluted (in dollars per share)	$ 0.89	$ 0.70

BCPC Balance Sheet

2024-03-31

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Current assets:
Cash and cash equivalents	$ 60,349	$ 64,447
Accounts receivable, net of allowances of $997 and $908 at March 31, 2024 and December 31, 2023 respectively	139,881	125,284
Inventories, net	110,381	109,521
Prepaid expenses	7,122	7,798
Other current assets	7,126	7,192
Total current assets	324,859	314,242
Property, plant and equipment, net	274,033	276,039
Goodwill	771,538	778,907
Intangible assets with finite lives, net	182,044	191,212
Right of use assets - operating leases	16,973	17,763
Right of use assets - finance lease	2,037	2,101
Other non-current assets	17,216	16,947
Total assets	1,588,700	1,597,211
Current liabilities:
Trade accounts payable	59,798	55,503
Accrued expenses	37,774	40,855
Accrued compensation and other benefits	10,902	17,228
Dividends payable	66	25,717
Income taxes payable	11,831	4,967
Operating lease liabilities - current	3,794	3,949
Finance lease liabilities - current	260	272
Total current liabilities	124,425	148,491
Revolving loan	301,569	309,569
Deferred income taxes	51,006	52,046
Operating lease liabilities - non-current	13,971	14,601
Finance lease liabilities - non-current	1,895	1,943
Other long-term obligations	17,043	16,577
Total liabilities	509,909	543,227
Commitments and contingencies (Note 15)
Stockholders' equity:
Preferred stock, $25 par value. Authorized 2,000,000 shares; none issued and outstanding	0	0
Common stock, $0.0667 par value. Authorized 120,000,000 shares; 32,423,400 and 32,254,728 shares issued and outstanding at March 31, 2024 and December 31, 2023, respectively	2,163	2,152
Additional paid-in capital	154,026	145,653
Retained earnings	926,474	897,488
Accumulated other comprehensive (loss) income	(3,872)	8,691
Total stockholders' equity	1,078,791	1,053,984
Total liabilities and stockholders' equity	$ 1,588,700	$ 1,597,211

About Balchem Corp

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets in the United States and internationally. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates. This segment also offers microencapsulation solutions for various applications; and human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. The Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production, and delivering nutrient supplements in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; and choline chloride, a nutrient for monogastric animal health. The Specialty Products segment offers ethylene oxide primarily for use in the health care industry; single use canisters for sterilizing re-usable devices; and ammonia. This segment also markets and sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as to reduce bacterial and mold contamination in shell and processed nut meats, processed spices, cacao beans, cocoa powder, raisins, figs, and prunes; and chelated minerals for high value crops. The company sells its products through sales force, independent distributors, and sales agents. Balchem Corporation was incorporated in 1967 and is headquartered in Montvale, New Jersey.

CEO	Mr. Theodore L. Harris
WEBSITE	balchem.com
INDUSTRY	Chemicals
EMPLOYEES	1284

Balchem Corp Frequently Asked Questions

What is the ticker symbol for Balchem Corp? What does BCPC stand for in stocks?

BCPC is the stock ticker symbol of Balchem Corp. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Balchem Corp (BCPC)?

As of Mon May 13 2024, market cap of Balchem Corp is 5.01 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of BCPC stock?

You can check BCPC's fair value in chart for subscribers.

What is the fair value of BCPC stock?

You can check BCPC's fair value in chart for subscribers. The fair value of Balchem Corp is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Balchem Corp is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for BCPC so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Balchem Corp a good stock to buy?

The fair value guage provides a quick view whether BCPC is over valued or under valued. Whether Balchem Corp is cheap or expensive depends on the assumptions which impact Balchem Corp's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for BCPC.

What is Balchem Corp's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Mon May 13 2024, BCPC's PE ratio (Price to Earnings) is 43.66 and Price to Sales (PS) ratio is 5.39. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. BCPC PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Balchem Corp's stock?

In the past 10 years, Balchem Corp has provided 0.115 (multiply by 100 for percentage) rate of return.